)
Journey Medical (DERM) investor relations material
Journey Medical Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription drugs for dermatological conditions in the U.S.
Product portfolio includes eight FDA-approved dermatology drugs, with recent launches such as Emrosi for rosacea and Luxamend for wound care.
Growth strategy centers on expanding the product portfolio through acquisitions, licensing, and development of new products, as well as out-licensing and lifecycle management.
Operates as a controlled subsidiary of Fortress Biotech, which maintains voting control via exclusive ownership of Class A Common Stock.
Financial performance and metrics
Audit report for 2024 and 2023 notes recurring losses from operations and substantial doubt about the ability to continue as a going concern.
Historical net tangible book value as of September 30, 2025, was $(2.8) million, or $(0.11) per share.
After the offering, as adjusted net tangible book value would be $23.6 million, or $0.78 per share, with immediate dilution of $6.49 per share to new investors at the assumed offering price.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for general corporate purposes, including working capital, R&D, licensing, sales and marketing, administrative expenses, operating expenses, and capital expenditures.
Management retains broad discretion over allocation of proceeds; funds may also be used for acquisitions or investments in complementary businesses, products, or technologies.
Pending use, proceeds may be invested in short-term, investment-grade, interest-bearing instruments or held as cash.
Next Journey Medical earnings date
Next Journey Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)